SFARI

All investigators who have received funds from SFARI and/or have used SFARI resources, biospecimens or data must follow these guidelines when publishing work.

The goal of the Pilot Progression Award is to provide continuing support for projects initiated during SFARI Pilot awards that have advanced significantly and produced insights that justify an extension.

SFARI Collaborations are a new funding mechanism that will provide substantive and stable funding support to multidisciplinary teams of investigators tackling critical issues in the autism research field. Collaborations will be led by a director who oversees interdisciplinary, synergistic research efforts across multiple laboratories. Investigative groups within a Collaboration will focus on the same conceptually unified topic but will incorporate different scientific disciplines, multiple levels of analysis, and will include a robust data-sharing infrastructure.
 
SFARI Collaborations have a maximum budget of up to $8,000,000, including 20 percent indirect costs, over an initial period of four years, with a possible three-year extension.
 
For our first Collaboration RFA, SFARI solicits applications to investigate sex differences in autism.

The goal of the Pilot Award is to provide early support for exploratory ideas considered higher risk but with the potential for transformative results, particularly those with novel hypotheses for autism. This funding mechanism is particularly suitable for investigators new to the autism field, though we encourage applicants to consult with experts in autism research to ensure their projects are relevant to the human condition. We encourage applications that propose research to link genetic or other ASD risk factors to molecular, cellular, circuit or behavioral mechanisms and set the stage for development of novel interventions, including work in human subjects.

Grants awarded through this RFA were intended to provide support for the investigation of key unresolved research questions in autism, particularly those that connect etiology to brain function and behavior. SFARI welcomed risk and novelty in Research Award proposals, but potential impact on the autism research field was the most important criterion. Competitive applications had preliminary data or other relevant groundwork that justifies substantial investment on the proposed topic.

SFARI launched the Autism Rat Models Consortium (ARC) in 2022 with a group of researchers funded through the original Autism Rat Models Consortium RFA. These researchers are using rats generated with SFARI funding that carry mutations in high-confidence genes that in humans significantly increase the likelihood of developing autism and related NDD. As part of the consortium, these same rat models are being evaluated through a comprehensive behavioral phenotyping pipeline established by the Simons Initiative for the Developing Brain (SIDB).